Soverini S; Colarossi S; Gnani A; Rosti G; Castagnetti F; Poerio A; Iacobucci I; Amabile M; Abruzzese E; Orlandi E; Radaelli F; Ciccone F; Tiribelli M; di Lorenzo R; Caracciolo C; Izzo B; Pane F; Saglio G; Baccarani M; Martinelli G; on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia (GIMEMA-CML), Contribution Of ABL Kinase Domain Mutations To Imatinib Resistance In Different Subsets Of Philadelphia-Positive Patients. By The GIMEMA Working Party On Chronic Myeloid Leukemia, «CLINICAL CANCER RESEARCH», 2006, 12(24), pp. 7374 - 7379 [Scientific article]
Soverini S.; Tasco G.; Grafone T.; Colarossi S.; Gnani A.; Rosti G.; Castagnetti F.; Palandri F.; Rondoni M.; Poerio A.; Iacobucci I.; Amabile M.; Baccarani M.; Casadio R.; Martinelli G., Dual Src/Abl inhibitor SKI-606 binding mode in BCR-ABL kinase hypothesized on the basis of molecular docking studies, in: , «HAEMATOLOGICA», 2006, 91(s1), pp. 27 - 27 (atti di: 11th Meeting of the European Hematology Association (EHA)., Amsterdam (Netherlands), 15-18/06/2006) [Abstract]
Merante S; Chichino G; Boveri E; Gottardi E; Soverini S; Cilloni D; Martinelli G, First case of an AIDS patient with systemic mast cell disease associated with Eosinophilia FIP1-positive treated with imatinib mesylate therapy, «JOURNAL OF CLINICAL ONCOLOGY», 2006, 24, pp. e6 - e7 [Scientific article]
Hughes T; Deininger M; Hochhaus A; Branford S; Radich J; Kaeda J; Baccarani M; Cortes J; Cross NC; Druker BJ; Gabert J; Grimwade D; Hehlmann R; Kamel-Reid S; Lipton JH; Longtine J; Martinelli G; Saglio G; Soverini S; Stock W; Goldman
JM., Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results., «BLOOD», 2006, 108, pp. 28 - 37 [Scientific article]
Martinelli G; Iacobucci I; Soverini S; Cilloni D; Saglio G; Pane F; Baccarani M., Monitoring minimal residual disease and controlling drug resistance in chronicmyeloid leukaemia patients in treatment with imatinib as a guide to clinicalmanagement., «HEMATOLOGICAL ONCOLOGY», 2006, 24, pp. 196 - 204 [Scientific article]
Martinelli, Giovanni; Iacobucci, Ilaria; Rosti, Gianantonio; Pane, F; Amabile, Marilina; Castagnetti, Fausto; Cilloni, D; Soverini, Simona; Testoni, Nicoletta; Specchia, G; Merante, S; Zaccaria, A; Frassoni, F; Saglio, G; Baccarani, Michele, Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients, «ANNALS OF ONCOLOGY», 2006, 17, pp. 495 - 502 [Scientific article]
S. Soverini;G. Martinelli;S. Colarossi;A. Gnani;F. Castagnetti;G. Rosti;C. Bosi;S. Paolini;M. Rondoni;P. P. Piccaluga;F. Palandri;P. Giannoulia;G. Marzocchi;S. Luatti;N. Testoni;I. Iacobucci;D. Cilloni;G. Saglio;M. Baccarani, Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia, «JOURNAL OF CLINICAL ONCOLOGY», 2006, 24, pp. e51 - e52 [Scientific article]
Soverini S; Martinelli G; Rosti G; Bassi S; Amabile M; Poerio A; Giannini B; Trabacchi E; Castagnetti F; Testoni N; Luatti S; de Vivo A; Cilloni D; Izzo B; Fava M; Abruzzese E; Alberti D; Pane F; Saglio G; Baccarani M., ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia, «JOURNAL OF CLINICAL ONCOLOGY», 2005, 23, pp. 4100 - 4109 [Scientific article]
Martinelli, Giovanni; Soverini, Simona; Rosti, Gianantonio; Baccarani, Michele, Dual tyrosine kinase inhibitors in chronic myeloid leukemia., «LEUKEMIA», 2005, 19, pp. 1872 - 1879 [Scientific article]
Iacobucci, I; Testoni, N; Rosti, G; Amabile, M; Poerio, A; Soverini, S; Colarossi, S; Gnani, A; Ottaviani, E; Castagnetti, F; Terragna, C; Renzulli, M; Grafone, T; Cilloni, D; Pane, F; Saglio, G; Baccarani, M; Martinelli, G, Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP., in: Abstract book, Atlanta, Georgia, 2005, 106, pp. 1100 - 1100 (atti di: 47^ American Society of Hematology Annual Meeting and Exposition, Atlanta, USA, 10-13 Dicembre 2005) [Abstract]
Martinelli G; Soverini S; Rosti G; Cilloni D; Baccarani M., New tyrosine kinase inhibitors in chronic myeloid leukemia, «HAEMATOLOGICA», 2005, 90, pp. 534 - 541 [Scientific article]
SOVERINI S; MARTINELLI G.; AMABILE M; POERIO A; BIANCHINI M; ROSTI G; PANE F; SAGLIO G; BACCARANI M., Denaturing-HPLC-based assay for detection of ABL mutations in Chronic Myeloid Leukemia patients resistant to Imatinib, «CLINICAL CHEMISTRY», 2004, 50, pp. 1205 - 1213 [Scientific article]
Piccaluga, PIER PAOLO; Malagola, Michele; Rondoni, Michela; Amabile, Marilina; Paolini, Stefania; Soverini, Simona; Gaitani, S; Visani, G; Baccarani, Michele; Martinelli, Giovanni, Dose increase of imatinib mesylate may overcome acquired resistance in
bcr/abl-positive acute lymphoid leukaemia, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2004, 72, pp. 302 - 303 [Scientific article]
ZINZANI P.; PULSONI A; PERROTTI A; SOVERINI S; ZAJA F; DE RENZO A; STORTI S; LAUTA VM; GUARDIGNI L; GENTILINI P; TUCCI A; MOLINARI AL; GOBBI M; FALINI B; FATTORI PP; CICCONE F; ALINARI L; MARTELLI M; PILERI S; TURA S; BACCARANI M., Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma., «JOURNAL OF CLINICAL ONCOLOGY», 2004, 22, pp. 2654 - 2661 [Scientific article]
BACCARANI M.; MARTINELLI G.; ROSTI G.; TRABACCHI E.; TESTONI N.; BASSI S.; AMABILE M.; SOVERINI S.; CASTAGNETTI F.; CILLONI D.; IZZO B.; DE VIVO A.; MESSA E.; BONIFAZI F.; POERIO A.; LUATTI S.; GIUGLIANO E.; ALBERTI D.; FINCATO G.; RUSSO D.; PANE F.; SAGLIO G.; GIMEMA WORKING PARTY ON CHRONIC MYELOID LEUKEMIA, Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia, «BLOOD», 2004, 104, pp. 4245 - 4251 [Scientific article]
